Cargando…
Time to rethink the reported disease-modifying treatment effects on cognitive outcomes: Methods and interpretative caveats
Autores principales: | Labiano-Fontcuberta, Andrés, Monreal, Enric, Benito-León, Julián |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474887/ https://www.ncbi.nlm.nih.gov/pubmed/36119690 http://dx.doi.org/10.3389/fneur.2022.995690 |
Ejemplares similares
-
Understanding Tremor in Multiple Sclerosis: Prevalence, Pathological Anatomy, and Pharmacological and Surgical Approaches to Treatment
por: Labiano-Fontcuberta, Andrés, et al.
Publicado: (2012) -
Caveats in the interpretation of natriuretic peptide levels
por: Chao, Chia-Ter
Publicado: (2011) -
Gut microbiome alterations in anti‐NMDA receptor encephalitis: caveats for result interpretation
por: Berzero, Giulia, et al.
Publicado: (2019) -
Caveat lector
por: Eldawlatly, Abdelazeem, et al.
Publicado: (2012) -
Caveat emptor
por: Aswani, Yashant, et al.
Publicado: (2015)